• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring.

作者信息

Dander E, Lucchini G, Vinci P, Introna M, Masciocchi F, Perseghin P, Balduzzi A, Bonanomi S, Longoni D, Gaipa G, Belotti D, Parma M, Algarotti A, Capelli C, Golay J, Rovelli A, Rambaldi A, Biondi A, Biagi E, D'Amico G

出版信息

Leukemia. 2012 Jul;26(7):1681-4. doi: 10.1038/leu.2011.384. Epub 2012 Jan 13.

DOI:10.1038/leu.2011.384
PMID:22289986
Abstract
摘要

相似文献

1
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring.间充质基质细胞治疗移植物抗宿主病：通过患者免疫监测了解体内生物学效应
Leukemia. 2012 Jul;26(7):1681-4. doi: 10.1038/leu.2011.384. Epub 2012 Jan 13.
2
Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study.间质基质细胞共输注可促进血小板恢复，而不增加单倍体造血干细胞移植后白血病复发：一项随机对照临床研究。
Stem Cells Dev. 2011 Oct;20(10):1679-85. doi: 10.1089/scd.2010.0447. Epub 2011 Feb 5.
3
Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.骨髓来源的常规而非克隆的间充质干细胞可抑制大鼠淋巴细胞增殖并预防移植物抗宿主病。
Cell Transplant. 2012;21(2-3):581-90. doi: 10.3727/096368911X605510.
4
CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation.CD4+CD25+ 调节性 T 细胞耗竭可增强异基因造血干细胞移植后供者淋巴细胞的移植物抗肿瘤效应。
Sci Transl Med. 2010 Jul 21;2(41):41ra52. doi: 10.1126/scitranslmed.3001302.
5
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.间充质干细胞共移植可能在非清髓性预处理 HLA mismatched 异基因移植后防止移植物抗宿主病 (GVHD) 导致的死亡，而不会消除移植物抗肿瘤效应。
Biol Blood Marrow Transplant. 2010 Jun;16(6):838-47. doi: 10.1016/j.bbmt.2010.01.011. Epub 2010 Jan 28.
6
A role for mesenchymal stem cells in the control of graft-versus-host disease.间充质干细胞在移植物抗宿主病控制中的作用。
Transplantation. 2009 May 15;87(9 Suppl):S53-4. doi: 10.1097/TP.0b013e3181a2876f.
7
Potential therapeutic applications of mesenchymal stromal cells.间充质基质细胞的潜在治疗应用。
Pathology. 2011 Oct;43(6):592-604. doi: 10.1097/PAT.0b013e32834ab72d.
8
Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation.在异基因造血干细胞移植后，早期免疫重建时 CD4(+)CD25(+)调节性 T 细胞和 TGF-β 的减少与移植物抗宿主病的发生和严重程度有关。
Leuk Res. 2010 Sep;34(9):1158-68. doi: 10.1016/j.leukres.2010.03.017. Epub 2010 Apr 20.
9
Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.一项关于第三方供体间充质基质细胞在成人脐血移植中应用的试点研究结果。
Cytotherapy. 2009;11(3):278-88. doi: 10.1080/14653240902807018.
10
Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.移植后移植物抗宿主病和无复发的移植与次要组织相容性抗原免疫监测相关。
Transfusion. 2010 Feb;50(2):418-28. doi: 10.1111/j.1537-2995.2009.02440.x. Epub 2009 Oct 15.

引用本文的文献

1
Mesenchymal stromal cell therapy: Progress to date and future outlook.间充质基质细胞疗法：迄今进展与未来展望。
Mol Ther. 2025 Jun 4;33(6):2679-2688. doi: 10.1016/j.ymthe.2025.02.003. Epub 2025 Feb 6.
2
Efficacy of off-the-shelf bone marrow mesenchymal stem cells for pediatric steroid-refractory acute graft-versus-host disease.现成的骨髓间充质干细胞治疗儿童类固醇难治性急性移植物抗宿主病的疗效
Blood Cell Ther. 2023 Dec 15;7(1):1-9. doi: 10.31547/bct-2023-020. eCollection 2024 Feb 25.
3
Novel therapies for graft versus host disease with a focus on cell therapies.
新型移植物抗宿主病治疗方法，重点是细胞疗法。
Front Immunol. 2023 Oct 5;14:1241068. doi: 10.3389/fimmu.2023.1241068. eCollection 2023.
4
The critical role of apoptosis in mesenchymal stromal cell therapeutics and implications in homeostasis and normal tissue repair.凋亡在间充质基质细胞治疗中的关键作用及其在体内平衡和正常组织修复中的意义。
Cell Mol Immunol. 2023 Jun;20(6):570-582. doi: 10.1038/s41423-023-01018-9. Epub 2023 Apr 25.
5
Current perspectives on mesenchymal stromal cell therapy for graft versus host disease.间充质基质细胞治疗移植物抗宿主病的当前观点。
Cell Mol Immunol. 2023 Jun;20(6):613-625. doi: 10.1038/s41423-023-01022-z. Epub 2023 May 10.
6
Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review.评估间充质干细胞治疗移植物抗宿主病的临床试验现状：系统评价。
Stem Cell Res Ther. 2022 Mar 4;13(1):93. doi: 10.1186/s13287-022-02751-0.
7
High-Throughput On-Chip Human Mesenchymal Stromal Cell Potency Prediction.高通量芯片上人骨髓间充质基质细胞效力预测。
Adv Healthc Mater. 2022 Jan;11(2):e2101995. doi: 10.1002/adhm.202101995. Epub 2021 Nov 11.
8
Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers.间充质基质细胞治疗移植物抗宿主病：基于机制的生物标志物。
Front Immunol. 2020 Jun 25;11:1338. doi: 10.3389/fimmu.2020.01338. eCollection 2020.
9
Adipose-derived stromal cells in regulation of hematopoiesis.脂肪来源的基质细胞在造血调控中的作用。
Cell Mol Biol Lett. 2020 Mar 5;25:16. doi: 10.1186/s11658-020-00209-w. eCollection 2020.
10
Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in Children.研究275：用于儿童类固醇难治性急性移植物抗宿主病的remestemcel-L更新扩展准入计划。
Biol Blood Marrow Transplant. 2020 May;26(5):855-864. doi: 10.1016/j.bbmt.2020.01.026. Epub 2020 Feb 7.